Tilray Brands Inc vs ProShares Ultra Semiconductors — how do they compare? Tilray Brands Inc trades at $4.27 (market cap $524.07M), while ProShares Ultra Semiconductors trades at $90.15. The key difference: ProShares Ultra Semiconductors is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| TLRY | USD | |
|---|---|---|
Market Cap | $524.07M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $21.00 | $113.53 |
52-Week Low | $4.23 | $39.58 |
Enterprise Value | $621.22M | — |
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $4.23, down 1.63% with bearish technical signals. The company reported revenue growth to $821.31M in 2025 but faces severe profitability challenges with a net loss of $2.19B and negative margins. Recent expansion includes medical cannabis launches in Panama and strategic acquisitions, while analyst consensus shows cautious sentiment with 65% hold ratings.
The outlook remains challenging due to persistent losses and high debt levels, though expansion initiatives and potential regulatory changes offer long-term opportunities. Key risks include execution on profitability, competitive pressures, and cannabis regulatory uncertainty.
USD trades at $83.24, up 1.19% with bearish technical signals from moving averages. Key support lies at $80 with resistance at $85. The company announced a $0.14 dividend for H1-2026, payable June 30, 2026. Recent news highlights include coverage of semiconductor sector volatility and earnings from various firms, though specific financials for USD are not detailed in the provided data.
The outlook remains cautious due to bearish technical indicators and limited fundamental data. Investment opportunity hinges on upcoming financial disclosures and sector performance, while risks include market volatility and reliance on broader economic conditions affecting semiconductor and related industries.
Trailing returns across standard periods
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →